Glioblastoma multiforme historical perspective

Jump to navigation Jump to search

Glioblastoma multiforme Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Glioblastoma multiforme from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Glioblastoma multiforme historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Glioblastoma multiforme historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Glioblastoma multiforme historical perspective

CDC on Glioblastoma multiforme historical perspective

Glioblastoma multiforme historical perspective in the news

Blogs on Glioblastoma multiforme historical perspective

Directions to Hospitals Treating Glioblastoma multiforme

Risk calculators and risk factors for Glioblastoma multiforme historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Marjan Khan M.B.B.S.[2]

Overview

The term “glioma” was first introduced by Rudolf Virchow in 1864. The suffix multiforme was meant to describe the various appearances of hemorrhage, necrosis, and cysts. the first successful removal of a brain tumor is credited to the Scottish neurosurgeon Sir William Macewen in 1879. The first successful removal of a brain tumor is credited to the Scottish neurosurgeon Sir William Macewen in 1879. In 1926 Percival Bailey and Harvey Cushing published “A Classification of the Tumors of the Glioma Group on a Histogenetic Basis with a Correlated Study of Prognosis” and the term “glioblastoma multiforme” (GBM) was coined. The WHO classification dropped the term multiforme and thus it is best referred as glioblastoma or grade IV astrocytoma.

Historical Perspective

  • The term “glioma” was first introduced by Rudolf Virchow in 1864.
  • The suffix multiforme was meant to describe the various appearances of hemorrhage, necrosis, and cysts.
  • the first successful removal of a brain tumor is credited to the Scottish neurosurgeon Sir William Macewen in 1879.
  • In 1922 Bailey and Cushing created a histological laboratory to examine Cushing’s collection of brain tumours found within his registry.
  • In 1926 Percival Bailey and Harvey Cushing published “A Classification of the Tumors of the Glioma Group on a Histogenetic Basis with a Correlated Study of Prognosis” and the term “glioblastoma multiforme” (GBM) was coined.
  • In 1940 neuropathologist Hans-Joachim Scherer made distinction between primary and secondary GBMs.
  • Initially known as “spongioblastoma multiforme”, Bailey and Cushing adopted the term glioblastoma to limit confusion.
  • In 1976 the International Classification of Diseases for Oncology (ICD-O) was created by the WHO for recording the incidence of malignancy and survival.
  • In 1993, GBM was removed from its original category and placed in the spectrum of “Astrocytic Tumours” and is classed as WHO grade IV astrocytoma.
  • The WHO classification dropped the term multiforme and thus it is best referred as glioblastoma or grade IV astrocytoma.

References


Template:WikiDoc Sources